knowledge -WSS

knowledge

author：entertainment 2025-09-27 19:21:45 - browse：7

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

LONDON — A U.K. government agency on Tuesday said that it won’t recommend Eli Lilly’s Mounjaro — part of a new class of medications that help patients lose weight — for people with type 2 diabetes without additional evidence.

Mounjaro, also known as tirzepatide, has U.S. approval for type 2 diabetes and is expected to win the regulatory green light for obesity later this year. It is one of several medications, along with Wegovy and Ozempic from Novo Nordisk, that have shown dramatic weight loss results, creating a surge in demand and blockbuster sales expectations.

But in draft guidance, the U.K.’s National Institute for Health and Care Excellence, which assesses the cost-effectiveness of medications, said it had asked Lilly for more data “to address the uncertainties in the clinical evidence, when compared to all relevant alternative treatments.” NICE recommendations are used by the National Health Service to determine whether to provide certain medications.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： CVS is willing to dump 10% of its Medicare Advantage members

explore

WSS

A new study asks: Are we harming blood donors by taking blood?

The White House hikes tariffs on plastic syringes made in China

Boston hospital trains restaurant workers on naloxone for overdoses

Connecting traumatic brain injury and domestic violence

Ripples from Flovent's discontinuation is killing children with asthma

These geoengineering technologies could help combat the climate crisis, scientists say

explore

knowledge

entertainment

Tori Bowie and the unacceptable rates of Black maternal death

Galapagos to make CAR

23andMe had bad news about my health. I wish a person had delivered it

Abbott's new stent may help patients with peripheral artery disease

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Ripples from Flovent's discontinuation is killing children with asthma

Walensky prepares to leave CDC — and Congress — behind

Australia's humpback populations rebound raising hopes of marine scientists

Hollywood unions extend contract negotiations for actors

Galapagos to make CAR

hotspot

Novo Nordisk testing Wegovy against alcohol

4th of July breaks record for highest global temperature ever measured

Galapagos to make CAR

HHS suspends federal funding for EcoHealth Alliance

Brain 'hot spot' may explain why African Americans feel greater pain

PhRMA sues HHS over Medicare drug price negotiation

entertainment

knowledge

explore

explore